We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04324996
Recruitment Status : Recruiting
First Posted : March 27, 2020
Last Update Posted : November 17, 2020
Chongqing Sidemu Biotech
Zhejiang Qixin Biotech
Information provided by (Responsible Party):
Chongqing Public Health Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 20, 2022
Estimated Study Completion Date : August 31, 2022